MedTrace Logo

Healthynsect Child Growth and Health Intervention Study

NCT06002620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2024-11-26

No results posted yet for this study

Summary

Malnutrition in all its forms is still a problem in resource limited settings including Kenya driven by low diet quality, food preparation and feeding practices including hygiene. Edible insects are currently of interest in alleviating malnutrition due to their energy density, high protein, vitamins and micronutrients (iron, zinc). Among the insects of preference are the crickets which have been shown to encourage the growth of probiotics (Bifidobacterium animalis) which support gut health increasing nutrient absorption and reduces systemic inflammation. Despite the nutritional value of insects and the contribution of cricket to improved gut health, there is limited evidence on the benefit of cricket based complementary food in the reduction of stunting amongst infants and young children. This study aim to determine the effect of integrating two nutrition interventions (cricket enriched porridge with nutrition education) on the infant and young child growth (stunting) and gut health in Alego Usonga Sub-County in Siaya County of rural western part of Kenya.

Conditions

  • Nutrition Status

Interventions

DIETARY_SUPPLEMENT

CSB+

standard care

DIETARY_SUPPLEMENT

Enriched nutrition food (CEF)

enriched cricket flour at 20%

BEHAVIORAL

Nutrition education

regular videos, sms reminders and face to face interaction

COMBINATION_PRODUCT

Combined nutrition and education

combined enriched cricket flour and nutrition education

Sponsors & Collaborators

  • Masinde Muliro University of Science and Technology

    collaborator UNKNOWN

  • Jomo Kenyatta University of Agriculture and Technology

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Silvenus O. Konyole, PhD · Masinde Muliro University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
6 Months
Max Age
7 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-09
Primary Completion
2024-01-16
Completion
2024-01-16

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002620 on ClinicalTrials.gov